Brief: Cyclacel Pharma Got Letter Notifying That Nasdaq Has Granted Co Until Jan 2, 2024 To Regain Compliance With Minimum Bid Price Rule

Bio Green Med Solution

07/07/2023 22:34

July 7 (Reuters) - Cyclacel Pharmaceuticals Inc
 CYCC.O :
    * CYCLACEL PHARMACEUTICALS:ON JULY 5, GOT LETTER NOTIFYING
THAT
NASDAQ HAS GRANTED CO UNTIL JAN 2, 2024 TO REGAIN COMPLIANCE
WITH MINIMUM BID PRICE RULE

Source text for Eikon:  ID: 
Further company coverage:  CYCC.O 

 ((Reuters.Briefs@thomsonreuters.com;))